Table 1 Perioperative characteristics of HCC patients
Age (years) | 70 ± 9 |
Gender (male/female) | 45/16 |
HBV/HCV/NBC | 12/32/15 |
Child-Pugh class (A/B) | 56/5 |
Diabetes mellitus (+/−) | 8/53 |
WBC count (/μl) | 5,000 ± 1,319 |
Lymphocyte count (/μl) | 1,484 ± 580 |
ICGR15 (%) | 16.1 ± 7.8 |
Albumin (g/dl) | 3.8 ± 0.4 |
Total bilirubin (mg/dl) | 0.81 ± 0.21 |
Cholinesterase (U/l) | 232 ± 64 |
Triglyceride (mg/dl) | 85 ± 43 |
Prothrombin time (%) | 92 ± 12 |
Platelet count (×104/μl) | 15 ± 8 |
AST (U/l) | 43 ± 27 |
ALT (U/l) | 42 ± 28 |
RBP (mg/dl) | 3.3 ±1.4 |
TTR (mg/dl) | 16 ±6 |
BTR | 5.09 ± 1.46 |
AFP (ng/ml) | 994 ± 5,028 |
PIVKA-II (mAU/ml) | 1,283 ± 2,209 |
Esophageal and/or gastric varices (+/−) | 15/46 |
Surgical procedure (limited/anatomic) | 35/26 |
Operation time (min) | 329 ± 130 |
Operative blood loss (ml) | 1,011 ± 1,351 |
Blood transfusion (+/−) | 9/52 |
Tumor size (cm) | 4.42 ± 4.09 |
Associated liver disease | Â |
(normal/fibrosis or hepatitis/cirrhosis) | 9/30/22 |
Morbidity (+/−) | 5/56 |